We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PLRX market cap is 774.68M. The company's latest EPS is USD -2.6783 and P/E is -4.79.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.48M | 1.97M | 1.33M | 248k | 0 |
| Operating Income | -31.95M | -37.4M | -42.1M | -47.33M | -47.69M |
| Net Income | -30.62M | -35.06M | -37.55M | -41.19M | -41.49M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 57.05M | 41.82M | 7.57M | 9.69M | 1.58M |
| Operating Income | -1.23M | -41.65M | -97.54M | -127.2M | -184.15M |
| Net Income | -6.86M | -41.53M | -97.26M | -123.32M | -161.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 377.18M | 350.61M | 597.88M | 574.89M | 540.46M |
| Total Liabilities | 40.19M | 37.27M | 35.96M | 41.83M | 37.42M |
| Total Equity | 336.99M | 313.34M | 561.92M | 533.07M | 503.05M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 119.06M | 295.53M | 221.22M | 350.61M | 512.15M |
| Total Liabilities | 9.08M | 12.47M | 22.16M | 37.27M | 38.58M |
| Total Equity | -76.3M | 283.06M | 199.06M | 313.34M | 473.58M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -63.39M | -94.63M | -30.28M | -55.04M | -91.26M |
| Investing | -170.23M | -150.2M | -174.21M | -197.19M | -158.93M |
| Financing | 226.57M | 226.85M | 273.33M | 273.49M | 274.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.75M | -37.27M | -75.44M | -94.63M | -116.36M |
| Investing | -17.93M | -210.87M | 73.7M | -150.2M | -127.01M |
| Financing | 45.54M | 213.21M | 2.53M | 226.85M | 274.41M |
| Market Cap | 774.68M |
| Price to Earnings Ratio | -4.79 |
| Price to Sales Ratio | 490.08 |
| Price to Cash Ratio | 12.23 |
| Price to Book Ratio | 1.63 |
| Dividend Yield | - |
| Shares Outstanding | 60.24M |
| Average Volume (1 week) | 488.12k |
| Average Volume (1 Month) | 335.78k |
| 52 Week Change | -42.36% |
| 52 Week High | 24.74 |
| 52 Week Low | 11.21 |
| Spread (Intraday) | 0.04 (0.31%) |
| Company Name | Pliant Therapeutics Inc |
| Address |
850 new burton road suite 201 dover, delaware 19904 |
| Website | https://pliantrx.com. |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
